Literature DB >> 30193398

Synthesis, Characterization and Photobiological Studies of Ru(II) Dyads Derived from α-Oligothiophene Derivatives of 1,10-Phenanthroline.

Susan Monro1, Colin G Cameron2, Xiaolin Zhu3, Katsuya L Colón2, Huimin Yin1, Tariq Sainuddin1, Marc Hetu1, Mitch Pinto1, Anderson Fuller1, Leah Bennett1, John Roque2, Wenfang Sun3, Sherri A McFarland1,2.   

Abstract

Three new bis(2,2'-bipyridine)-heteroleptic Ru(II) dyads incorporating thienyl groups (n = 1-3, compounds 1, 2 and 3, respectively) appended to 1,10-phenanthroline were synthesized and characterized to investigate the impact of n on the photophysical and photobiological properties within the series. All three complexes showed unstructured emission near 618 nm from a triplet metal-to-ligand charge transfer (3 MLCT) state with a lifetime (τem ) of approximately 1 μs. Transient absorption measurements revealed an additional excited state that was nonemissive and long-lived (τTA  = 43 μs for 2 and 27 μs for 3), assigned as a triplet intraligand (3 IL) state that was accessible only in 2 and 3. All three complexes were strong singlet oxygen (1 O2 ) sensitizers, with quantum yields (Φ∆ ) for 2 and 3 being the largest (74-78%), and all three were photocytotoxic to cancer cells with visible light activation in the order: 3 > 2 > 1. Cell-free DNA photodamage followed the same trend, where potency increased with decreasing 3 IL energy. Compounds 2 and 3 also showed in vitro photobiological effects with red light (625 nm), where their molar absorptivities were <100 m-1  cm-1 . These findings highlight that Ru(II) dyads derived from α-oligothiophenes directly appended to 1,10-phenanthroline-namely 2 and 3-possess low-lying 3 IL states that are highly photosensitizing, and they may therefore be of interest for photobiological applications such as photodynamic therapy (PDT).
© 2018 The American Society of Photobiology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30193398      PMCID: PMC6347502          DOI: 10.1111/php.13012

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  28 in total

1.  Efficiency of the photoprocesses leading to singlet oxygen (1 delta g) generation by alpha-terthienyl: optical absorption, optoacoustic calorimetry and infrared luminescence studies.

Authors:  J C Scaiano; R W Redmond; B Mehta; J T Arnason
Journal:  Photochem Photobiol       Date:  1990-10       Impact factor: 3.421

2.  Synthesis and spectroscopic characterization of CN-substituted bipyridyl complexes of Ru(II).

Authors:  Catherine E McCusker; James K McCusker
Journal:  Inorg Chem       Date:  2011-02-02       Impact factor: 5.165

Review 3.  DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.

Authors:  Rahul Palchaudhuri; Paul J Hergenrother
Journal:  Curr Opin Biotechnol       Date:  2007-11-07       Impact factor: 9.740

4.  An Overview Of Photosubstitution Reactions Of Ru(II) Imine Complexes And Their Application In Photobiology And Photodynamic Therapy.

Authors:  Jessica K White; Russell H Schmehl; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-06-18       Impact factor: 2.545

5.  Exploitation of long-lived 3IL excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model.

Authors:  Richard Lincoln; Lars Kohler; Susan Monro; Huimin Yin; Mat Stephenson; Ruifa Zong; Abdellatif Chouai; Christopher Dorsey; Robie Hennigar; Randolph P Thummel; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2013-11-04       Impact factor: 15.419

6.  Photophysics of Ru(II) Dyads Derived from Pyrenyl-Substitued Imidazo[4,5-f][1,10]phenanthroline Ligands.

Authors:  Christian Reichardt; Mitch Pinto; Maria Wächtler; Mat Stephenson; Stephan Kupfer; Tariq Sainuddin; Julien Guthmuller; Sherri A McFarland; Benjamin Dietzek
Journal:  J Phys Chem A       Date:  2015-04-20       Impact factor: 2.781

7.  Conjugation length dependent ground and excited state electronic behavior in oligothienyl ru complexes.

Authors:  Carolyn Moorlag; Biprajit Sarkar; Carlos N Sanrame; Peter Bäuerle; Wolfgang Kaim; Michael O Wolf
Journal:  Inorg Chem       Date:  2006-09-04       Impact factor: 5.165

8.  Theoretical Exploration of Type I/Type II Dual Photoreactivity of Promising Ru(II) Dyads for PDT Approach.

Authors:  Marta Erminia Alberto; Jenny Pirillo; Nino Russo; Carlo Adamo
Journal:  Inorg Chem       Date:  2016-10-18       Impact factor: 5.165

9.  Long-lived, directional photoinduced charge separation in RuII complexes bearing laminate polypyridyl ligands.

Authors:  Marek B Majewski; Norma R de Tacconi; Frederick M MacDonnell; Michael O Wolf
Journal:  Chemistry       Date:  2013-04-23       Impact factor: 5.236

10.  Excited State Dynamics of a Photobiologically Active Ru(II) Dyad Are Altered in Biologically Relevant Environments.

Authors:  Christian Reichardt; Kilian R A Schneider; Tariq Sainuddin; Maria Wächtler; Sherri A McFarland; Benjamin Dietzek
Journal:  J Phys Chem A       Date:  2017-07-25       Impact factor: 2.781

View more
  9 in total

1.  Strained, Photoejecting Ru(II) Complexes that are Cytotoxic Under Hypoxic Conditions.

Authors:  John Roque; Dmytro Havrylyuk; Patrick C Barrett; Tariq Sainuddin; Julia McCain; Katsuya Colón; William T Sparks; Evan Bradner; Susan Monro; David Heidary; Colin G Cameron; Edith C Glazer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2019-12-06       Impact factor: 3.421

2.  Synthesis and Characterization of Ru(II) Complexes with π-Expansive Imidazophen Ligands for the Photokilling of Human Melanoma Cells.

Authors:  Goutam Ghosh; Huimin Yin; Susan M A Monro; Tariq Sainuddin; Lloyd Lapoot; Alexander Greer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2020-01-09       Impact factor: 3.421

3.  Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States.

Authors:  Liubov M Lifshits; John A Roque; Elamparuthi Ramasamy; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  J Photochem Photobiol       Date:  2021-09-15

Review 4.  Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.

Authors:  Elizabeth T Papish; Olaitan E Oladipupo
Journal:  Curr Opin Chem Biol       Date:  2022-04-25       Impact factor: 8.972

5.  Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia.

Authors:  John A Roque Iii; Houston D Cole; Patrick C Barrett; Liubov M Lifshits; Rachel O Hodges; Susy Kim; Gagan Deep; Antonio Francés-Monerris; Marta E Alberto; Colin G Cameron; Sherri A McFarland
Journal:  J Am Chem Soc       Date:  2022-04-28       Impact factor: 16.383

6.  Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Evan Bradner; Ge Shi; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Inorg Chem       Date:  2020-10-30       Impact factor: 5.165

7.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

8.  NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.

Authors:  Liubov M Lifshits; John A Roque; Houston D Cole; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  Chembiochem       Date:  2020-09-25       Impact factor: 3.164

9.  String-Attached Oligothiophene Substituents Determine the Fate of Excited States in Ruthenium Complexes for Photodynamic Therapy.

Authors:  Avinash Chettri; Kilian R A Schneider; Houston D Cole; John A Roque; Colin G Cameron; Sherri A McFarland; Benjamin Dietzek
Journal:  J Phys Chem A       Date:  2021-08-09       Impact factor: 2.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.